Related Experiment Videos
Ambulatory system to aid in decision making and risk stratification in postinfarction patients
M Pascual1, M A González, J Márquez Montes
1Bioengineering Laboratory, Clínica Puerta de Hierro, Madrid, Spain.
Insights
A new portable ECG system aids in managing ischemic heart disease and ventricular arrhythmias. It integrates multiple parameters for improved risk stratification and patient follow-up.
Area of Science:
- Cardiology
- Medical Technology
- Biomedical Engineering
Background:
- Effective management of cardiovascular diseases like ischemic heart disease and ventricular arrhythmias requires integrated clinical and electrophysiological data.
- Current patient follow-up and treatment efficacy assessment methods can be enhanced with specialized tools.
- Decision-making in cardiovascular patient care benefits from comprehensive parameter analysis and risk stratification.
Purpose of the Study:
- To design and present a simple, low-cost, portable electrocardiograph (ECG) processing system.
- To integrate and analyze various ECG-derived parameters, alongside Doppler ultrasound and epidemiological data, for enhanced patient management.
- To develop a system for improved risk stratification, mortality prediction, and assessment of treatment efficacy in patients with ischemic heart disease and ventricular arrhythmias.
Main Methods:
- Development of a portable system comprising an electrocardiograph and a laptop PC.
- ECG analysis to determine arrhythmia incidence, heart rate variability, QT dispersion, ventricular hypertrophy criteria, and late potentials.
- Input of left ventricular ejection fraction, diastolic function (Doppler ultrasound), and epidemiological data.
- Integration of these parameters to generate second-level indicators for predictive capacity.
- Implementation of a patient database for disease monitoring and treatment evaluation.
Main Results:
- The system successfully determines key electrophysiological parameters from ECGs.
- Integration of diverse data provides enhanced predictive indicators for long-term patient follow-up.
- The system facilitates risk stratification for mortality and arrhythmic events in the target patient population.
- A comprehensive database enables effective disease course tracking and treatment efficacy assessment.
Conclusions:
- The developed portable ECG processing system offers a valuable, cost-effective tool for managing patients with ischemic heart disease and ventricular arrhythmias.
- This integrated approach enhances decision-making, risk stratification, and patient follow-up compared to analyzing parameters separately.
- The system has the potential to improve clinical outcomes and facilitate multicenter studies in cardiovascular medicine.
Abstract:
Knowledge of the clinical and electrophysiological features of certain cardiovascular risk groups, the adaptation and specialization of clinical protocols, the availability of tools to make determinations for use in patient follow-up and to assess the efficacy of the treatments applied, and the proper processing of different parameters can aid in decision making, leading to the application of a given therapeutic approach, and can facilitate the performance of group and multicenter studies. To address these needs, a simple, low-cost, portable ECG processing system has been designed that complements the current techniques for managing patients with ischemic heart disease and nonmalignant ventricular arrhythmias. This system, consisting of an electrocardiograph and a laptop PC, determines the following parameters on the basis of the ECG: incidence of arrhythmia, heart rate variability, QT dispersion, ECG criteria for ventricular hypertrophy and late potentials. Left ventricular ejection fraction and diastolic function (according to Doppler ultrasound) and other basic epidemiological parameters are typed in. Moreover, the system integrates these parameters, which have usually been considered separately, to arrive at second-level indicators with a greater predictive capacity during the long-term follow-up of patients with ischemic heart disease and ventricular arrhythmias, thus providing an idea of the risk of mortality and the onset of arrhythmic events and allowing risk stratification in this patient population. Finally, the system includes a database of all the patients analyzed, with tools that make it possible to follow the course of their disease and to assess the efficacy of the treatments applied.